144 related articles for article (PubMed ID: 8562414)
1. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation.
Isaksson E; Björkholm M; Holm G; Johansson B; Nilsson B; Mellstedt H; Osterborg A
Br J Haematol; 1996 Jan; 92(1):71-6. PubMed ID: 8562414
[TBL] [Abstract][Full Text] [Related]
2. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
van de Poel MH; Coebergh JW; Hillen HF
Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
6. [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ].
Decaux O; Cazalets-Lacoste C; Cador-Rousseau B; Laurat E; Sebillot M; Bracq J; Jego P; Leblay R; Grosbois B
Rev Med Interne; 2002 Sep; 23(9):751-8. PubMed ID: 12378828
[TBL] [Abstract][Full Text] [Related]
7. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
8. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
10. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA
Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274
[TBL] [Abstract][Full Text] [Related]
12. [Malignant transformation of monoclonal gammopathy of undetermined significance].
Decaux O; Avet-Loiseau H; Grosbois B
Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
[TBL] [Abstract][Full Text] [Related]
13. Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment.
Lindemalm C; Mellstedt H; Nilsson B; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):749-53. PubMed ID: 3115783
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
Lolin YI; Chow J; Wickham NW
Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
[TBL] [Abstract][Full Text] [Related]
15. Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosis.
Osterborg A; Nilsson B; Björkholm M; Holm G; Johansson B; Lindemalm C; Petterson D; Ahre A; Mellstedt H
Eur J Haematol; 1987 Feb; 38(2):173-8. PubMed ID: 3109935
[TBL] [Abstract][Full Text] [Related]
16. Alterations of peripheral blood B-lymphocyte populations in plasma cell disorders.
Dillman RO; Royston I; Meserve BL; Griffiths JC
Cancer; 1981 Nov; 48(10):2211-7. PubMed ID: 6794900
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
Pasqualetti P; Casale R
Biomed Pharmacother; 1997; 51(2):74-8. PubMed ID: 9161471
[TBL] [Abstract][Full Text] [Related]
18. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
[TBL] [Abstract][Full Text] [Related]
19. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy in general practice. Diagnostic value of typing and quantitation of immunoglobulins.
Schmidt EB; Møller-Petersen J
Scand J Prim Health Care; 1985 May; 3(2):91-4. PubMed ID: 3933073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
